Hint mode is switched on Switch off
For swift navigation between sections

Revvity
LEI 549300IKL1SDPFI7N655

Organization name
Revvity Inc
Country name
USA
Country of registration
USA
Industry
Medical Devices
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
3,226 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Revvity Inc is a provider of technology, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company’s advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. In February 2011, it acquired chemagen Biopolymer-Technologie AG (chemagen). In March 2011, it acquired ArtusLabs, Inc. (ArtusLabs). In March 2011, it acquired specified assets and assumed specified liabilities of ID Biological Systems, Inc. (IDB). In April 2011, it acquired CambridgeSoft Corporation (CambridgeSoft). In May 2011, it acquired Geospiza, Inc. (Geospiza). In May 2011, it acquired Labtronics, Inc. (Labtronics). In June 2011, it acquired Dexela Limited (Dexela). In November 2011, it acquired Caliper Life Sciences, Inc. (Caliper).

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • LEI
    549300IKL1SDPFI7N655
  • SIC
    3826 LABORATORY ANALYTICAL INSTRUMENTS
  • ICB
    4,500 Health Care
  • NAICS
    334,516 Analytical Laboratory Instrument Manufacturing
  • CIK
    0000031791
  • EIN
    04-2052042
Registration is required to get access.